Xenetic Biosciences, Inc.
XBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534525
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Xenetic Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Xenetic Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Parslow James F | Interim CEO and CFO | 100,000 | Apr 23, 2026 | 1 |
| Kornberg Roger D. | Director | – | Jan 5, 2026 | 1 |
| Dastoor Firdaus J. | Director | – | Jan 5, 2026 | 1 |
| Vinogradov Alexey Andreevich | Director | – | Jan 5, 2026 | 1 |
| Borisenko Grigory G. | Director | – | Jan 5, 2026 | 1 |
| Mizrahy Moshe | Director | – | Dec 18, 2023 | 0 |
| Eisenberg Jeffrey F | Chief Executive Officer | – | Dec 13, 2023 | 0 |
| Lockshin Curtis | Chief Sciencific Officer | – | Dec 13, 2023 | 0 |
| Logal Adam | Director | – | Dec 8, 2023 | 0 |
| Callaway James Eric | Director | – | Dec 8, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.